UFP Technologies, Inc. (UFPT)

UFP Technologies' stock price experienced a significant decline over the past six months, with the share price decreasing by 35.23% from October 1, 2024, to September 30, 2025. Key events impacting the stock include the Q2 2025 earnings call, where the company reported strong revenue growth but anticipated manufacturing inefficiencies in Q3. Acquisitions of Universal Plastics & Engineering Company, Inc. and Techno Plastics Industries, Inc. in July 2025, and plans to acquire AQF Limited were also announced. InvestingPro's Fair Value models identified UFP Technologies as overvalued in November 2024. The company reported a 41.1% increase in net sales for Q1 2025, primarily due to growth in the medical market.

The provided information does not explicitly detail the demand seasonality for UFP Technologies, Inc.'s products and services. However, given its significant focus on the medical market, demand might be less susceptible to typical consumer seasonal fluctuations. The consistent need for medical devices, sterile packaging, and related components suggests a relatively stable demand profile, with growth in robotic-assisted surgery and other medical markets indicating increasing demand for its specialized products.

UFP Technologies, Inc. is a multinational company specializing in the development and custom manufacturing of solutions for medical devices, sterile packaging, and other engineered products, operating within the Health Care Products Manufacturing sector. The company's offerings include single-use medical devices and components, sterile packaging solutions like FlexShield®, engineered products for various industries, custom-engineered foam and thermoplastic components, and thermoformed plastic products.

UFP Technologies has a multinational presence with operations in the United States and Mexico, with its headquarters in Newburyport, Massachusetts. Through acquisitions, the company has expanded its international footprint to five countries. It primarily markets and sells its products in the United States through a direct sales force and independent manufacturer representatives.

UFP Technologies has a reputation as a trusted partner for medical devices and sterile packaging, considered an important link in the medical device supply chain. The company's expertise in customized solutions and focus on innovation contribute to customer loyalty. The company's MedTech business accounted for over 90% of its revenue as of 2024, and it was added to the S&P SmallCap 600 index in 2023, positively impacting its visibility. No specific negative events significantly impacted the company's brand reputation in the past year.

UFP Technologies has significant institutional ownership, with 593 institutional owners and shareholders holding a total of 11,318,689 shares, accounting for approximately 89.99% to 115.54% of the company. Major institutional owners include BlackRock, Inc., Wasatch Advisors Inc, and Vanguard Group Inc. Individual ownership is around 3.74%, with the largest individual shareholder being William Shaw, owning 288,924 shares, representing 3.75% of the company.